Advancements Driving Growth in the UK Peptide Anticoagulant Drugs Market
The UK Peptide Anticoagulant Drugs Market is expected to experience significant growth, projected to reach approximately $1.4 billion by 2035, representing a compound annual growth rate (CAGR) of 8.61%. This surge is driven by a notable increase in demand for innovative therapies addressing thromboembolic disorders and enhanced awareness regarding anticoagulant therapies. The market size in...
0 Commentaires 0 Parts 2 Vue 0 Aperçu